SAPPORO CLINICAL LABORATORY INC.JP:9776

Market cap
¥8.3B
P/E ratio
12.2x
2014/032015/032016/032017/032018/032019/032020/032021/032022/032023/032024/032025/03
Cash and cash equivalents -2,6643,0683,1354,0574,4782,7282,3612,9913,6643,9762,941
Total cash & short-term investments-2,6643,0683,1354,0574,4782,7282,3612,9913,6643,9762,941
Accounts receivable, net-2,9402,8622,7252,7672,6522,6082,779----
Inventories-533447523465525452433410432501531
Total current assets-6,3176,5616,6117,4897,7625,9325,9137,2307,3117,6976,636
Property, plant and equipment, net-2,0232,2022,3442,3792,1094,8657,7588,1288,4498,1918,906
Marketable securities, non-current -152115137133165134177142150210235
Total non-current assets-2,8482,9853,1163,1022,9155,6218,5998,9209,2108,9849,815
Total assets -9,1659,5469,72810,59110,67811,55314,51116,14916,52116,68116,451
Accounts payable-2,3822,1872,0412,0671,8652,1692,2942,2592,1792,2362,154
Short-term debt-252213--------
Long-term debt, current -202013---134134134135134
Total current liabilities-2,9052,7992,4882,7292,4312,7963,1063,2823,2573,3073,121
Long-term debt, non-current -3513----1,8661,7321,5991,4651,331
Total non-current liabilities-2982632552652652942,1332,5302,3842,1911,936
Total liabilities -3,2043,0622,7442,9942,6963,0905,2395,8115,6405,4985,057
Common stock and paid-in capital -1,9991,9991,9991,9991,9991,9991,9991,9991,9991,9991,999
Retained earnings-4,4354,9845,4596,1106,5957,0897,8498,8139,3049,6089,995
Stockholders' equity5,8255,9616,4846,9847,5977,9818,4639,27210,33710,88011,18311,394
Total debt-815527---2,0001,8661,7321,6001,465
Net debt--2,584-3,013-3,108----361-1,125-1,932-2,376-1,476
D/E ratio (%)-1.40.90.4---21.618.115.914.312.9
Working capital-----